Clinical Trial Update: Assessment of the Transfer of Using Levonorgestrel Intrauterine System (LNG IUS) as a Contraceptive to Using it as Part of Hormone Replacement Therapy (HRT). [Phase 3]

View source ↗

Summary

A Phase 3 trial sponsored by Bayer evaluated repurposing the levonorgestrel intrauterine system (LNG IUS) from contraception to be used as part of hormone repla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• Levonorgestrel intrauterine system (LNG-IUS) (Levonorgestrel intrauterine system)

Snippet

Sponsor: Bayer | Conditions: Menopause | Phase 3 | Status: COMPLETED | Results posted: 2009-11-19